Skip to main content
Fig. 7 | Respiratory Research

Fig. 7

From: Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation

Fig. 7

Unique immune populations arise in RSV, OVA and OVA-RSV treated animals at day 4 after RSV infection. As with previous experiments, BAL and perfused lung tissue were collected for immune cell quantitation. A–D, I, J Total lung leukocytes were determined in BAL and E–H, K, L lung tissue following previous OVA and RSV challenge ± anti-IL-33 treatment. Results are representative of three separate experiments. Bars represent the cell count for the indicated populations ± SEM. Mixed ANOVA was used to assess the interaction of anti-IL-33 within the other independent treatments, OVA and RSV. # indicates a significant effect of anti-IL-33 antibody within a treatment groups (P < 0.05). As before * indicates a difference (P < 0.05) between treatment groups

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us